Mark Thursz is Professor of Hepatology at Imperial College where he is head of the Digestive Diseases Division and lead clinician for hepatology at St Mary’s Hospital, London. His clinical interests are in viral hepatitis, alcoholic and fatty liver disease.Prof. Thursz is

Prof. Thursz is chief investigator on two multi-centre trials: The warfarin anticoagulation for liver fibrosis in patients transplanted for hepatitis C (WAFT-C) trial and the steroids or pentoxifylline for alcoholic hepatitis (STOPAH) trial. He is chief investigator on the PROLIFICA programme in West Africa.
Read more.

Data Protection and Privacy Policy

EASL International Liver Foundation

We take the protection of your personal data seriously, meaning that we process your personal data with due care and in accordance with applicable data protection laws.

Consent

Please note that by clicking the box “I agree”, you explicitly agree to the processing of your personal data for the purposes and pursuant to the terms and conditions mentioned in our Data Protection and Privacy Policy available at here“.

Contact

For any question or request, please contact us at EASL International Live Foundation, Rue Daubin 7, 1203 Geneva, Switzerland, telephone 0041 (0)22 552 2497 gdpr@easl-ilf.org